Physician

David Gerard Aliabadi, M.D.

According to 2025 Medicare claims, David Aliabadi, M.D. (NPI: 1962404723) practices cardiology in the Oxnard-Thousand Oaks-Ventura, CA market, with the plurality of this provider's patient population coming from Ventura, CA. This provider's primary affiliated billing organization is DAVID ALIABADI MD INC. (NPI: 1336168525) and primary practice location at 91360-8042.

Aliabadi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,076 traditional Medicare patients, billed 12,326 HCPCS/CPT codes, and received $1,376,239 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 10,473 prescription claims across 1,337 beneficiaries totaling $2,146,666 in drug costs, led by Eliquis (Apixaban). DME data shows 159 claims. Open Payments data shows 104 records totaling $3,231. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $620,919 to $1,376,239. Similarly, Part D prescription costs have moved sharply higher in recent years, from $460,523 to $2,146,666. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $19,131 and ending at $11,727.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,624	6,927	$620,919
2016	1,409	7,335	$684,578
2017	1,255	6,731	$628,750
2018	1,364	7,280	$691,218
2019	1,932	9,590	$857,652
2020	1,686	9,183	$839,992
2021	2,000	11,529	$1,081,467
2022	2,182	12,029	$1,058,979
2023	2,147	11,932	$1,347,278
2024	2,076	12,326	$1,376,239

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	476	4,646	$460,523
2016	560	5,322	$551,683
2017	610	5,402	$618,431
2018	700	5,833	$706,736
2019	750	6,781	$942,564
2020	884	7,463	$1,088,762
2021	1,203	9,412	$1,531,710
2022	1,268	10,394	$1,979,676
2023	1,283	10,032	$2,301,362
2024	1,337	10,473	$2,146,666

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	15	160	$8,021
2016	N/R	81	$3,715
2017	N/R	77	$3,009
2018	N/R	42	$1,302
2019	98	135	$4,150
2020	252	624	$20,400
2021	104	265	$8,076
2022	149	330	$10,696
2023	70	238	$9,159
2024	23	159	$5,649

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	804	919	$164
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,782	3,004	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	882	1,306	$71
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	494	532	$61
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,889	2,530	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	602	36,550	$702,130
Repatha Sureclick	Evolocumab	429	25,240	$476,458
Xarelto	Rivaroxaban	165	12,309	$225,770
Entresto	Sacubitril/Valsartan	132	7,626	$164,526
Farxiga	Dapagliflozin Propanediol	74	4,756	$87,657

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	23	$2,367
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	27	$1,322
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	N/R	22	$813
A7038	Filter, disposable, used with positive airway pressure device	N	11	30	$344
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	12	$306

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	100	$1,642	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$1,589	Medtronic, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Gerard Aliabadi, M.D.?

Tedicare shows public-source Medicare data for David Gerard Aliabadi, M.D. (NPI 1962404723), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Gerard Aliabadi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Gerard Aliabadi, M.D.?

David Gerard Aliabadi, M.D. is linked to DAVID ALIABADI MD INC. (billing NPI 1336168525) in the available physician profile data.

Does David Gerard Aliabadi, M.D. have Open Payments data?

David Gerard Aliabadi, M.D. has 104 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.